Filter
745
Text search:
drug
manufacturing
Featured
Recommendations
61
New Publications
187
Language
Document type
No document type
359
Studies & Reports
141
Guidelines
131
Manuals
44
Strategic & Response Plan
41
Fact sheets
11
Situation Updates
9
Training Material
3
Resource Platforms
3
Infographics
2
Brochures
1
Countries / Regions
Global
36
India
35
Kenya
32
Nigeria
21
Ghana
21
Uganda
19
Ethiopia
17
Sierra Leone
13
Tanzania
13
South Africa
13
Western and Central Europe
13
Nepal
12
Zambia
12
Bangladesh
12
Africa
11
Malawi
9
Botswana
9
Liberia
8
Zimbabwe
8
Ukraine
8
Lesotho
8
Rwanda
7
Namibia
7
Myanmar / Burma
7
South–East Asia Region
7
Philippines
6
Indonesia
5
Latin America and the Carribbean
5
Eastern Europe
5
Eswatini/ Swaziland
4
Haiti
3
Cambodia
3
Thailand
3
East and Southern Africa
3
West and Central Africa
3
Albania
3
Tajikistan
3
Russia
3
Senegal
2
Cameroon
2
Pakistan
2
Germany
2
Mozambique
2
Sudan
2
Western Pacific Region
2
Asia
2
Laos
2
Moldova
2
Vietnam
2
Guinea
1
Congo, Democratic Republic of
1
USA
1
South Sudan
1
Syria
1
China
1
Benin
1
Brazil
1
Serbia
1
Madagascar
1
Sri Lanka
1
Middle East and North Africa
1
Eastern Europe and Central Asia
1
Solomon Islands
1
Uzbekistan
1
Australia
1
Turkmenistan
1
Maldives
1
Mauritius
1
Authors & Publishers
Publication Years
Category
Countries
303
Clinical Guidelines
58
Pharmacy & Technologies
33
Public Health
27
Key Resources
20
Women & Child Health
13
Capacity Building
6
Toolboxes
Pharmacy
83
AMR
81
COVID-19
53
HIV
47
TB
38
Mental Health
34
Malaria
23
NTDs
20
Planetary Health
16
Ebola & Marburg
14
NCDs
13
Health Financing Toolbox
12
Rapid Response
11
Global Health Education
11
Conflict
5
Specific Hazards
5
Caregiver
5
2.0 Rapid Response
5
Cholera
3
Natural Hazards
3
Polio
2
Disability
1
Refugee
1
Zika
1
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 29.
Constituting the fourth part of the World Drug Report 2022, this booklet focuses on the market dynamics of various stimulants – cocaine, amphetamines and “ecstasy” – and of NPS.
The first chapter contains an analysis of the global market fo
...
Three Years After Enactment of the Drug Quality and Security Act
Good Manufacturing Practice (GMP) describes a set of principles and procedures that, when followed, ensure that medicines and related substances are of high quality, safety and efficacy. SAHPRA is a
participating authority of the Pharmaceutical Ins
...
World Drug Report 2018
-3-
World Drug Report 2018
-2-
The booklet starts with a general overview of how illicit drugs and the environment are linked within the bigger picture of the Sustainable Development Goals, climate change and environmental sustainability. It highlights direct and indirect linkages and gives examples of the significant local and i
...
World Drug Report 2017
-5-
Accessed: 14.03.2019
The Trends and Developments report presents a top-level overview of the drug phenomenon in Europe, covering drug supply, use and public health problems as well as
...
Pharmaceutical News
Evaluation of Saccharide Content of the WHO 2nd International Standard for Haemophilus Influenzae Polysaccharide Polyribosyl Ribitol Phosphate (PRP) by HPAECPAD Analysis Following Acid Hydrolysis
Consultation Documents
Lamivudine and tenofovir disoproxil fumarate tablets (lami
...
Strategic Overview
Revised Edition
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used in their clinical practice. Continuous evaluation o
...
Table of contents:
- Preface
- Introductory note and acknowledgements
- Commentary
- Chapter 1: Drug supply and the market
- Chapter 2: Drug use prevalence and trends
- Chapter 3:
...
The World Drug Report 2022 is aimed not only at fostering greater international cooperation to counter the impact of the world drug problem on health, governance and security, but also, with its spe
...
CHAPTER 206 | An Act to establish a national drug policy and a national drug authority to ensure the availability, at all times, of essential, efficacious and cost-effective drugs to the entire popu
...